Detalhe da pesquisa
1.
Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results.
Biol Blood Marrow Transplant
; 21(6): 1074-82, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25805300
2.
An open-label phase I/II study of cyclophosphamide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed myeloma.
Eur J Haematol
; 95(5): 426-35, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25600676
3.
Phase II study of pegylated liposomal doxorubicin, low-dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma.
Am J Hematol
; 89(1): 62-7, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24030918